Work

Reply to the Letter by Mazzitelli M. et al. Regarding “Impact of COVID ‐19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase”

Year: 2026

Type: letter

Abstract: regarding our study on the impact of COVID-19 in patients with hematologic malignancies during the late pandemic phase.The authors emphasize the omission of early antiviral treatments and monoclonal antibodies (mAbs) as confounding factors in our analysis.We welcome the opportunity to clarify our methodological choices and provide further insights based on our broader clinical experience.

Source: Cancer Medicine

DOI: 10.1002/cam4.72326

Authors: Daniele Caracciolo, Pierfrancesco Tassone, Pierosandro Tagliaferri

Institutions: Magna Graecia University, Azienda Ospedaliero-Universitaria "Renato Dulbecco"

Language: English

Topic: COVID-19 and healthcare impacts

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,700

OpenAlex ID: W7220735819

Cites: 8

Cited by:

Related to: 10